Leigh Ann Bruhn, director of Avalere Health, addresses results from "DIMENSIONS of Specialty Pharmaceuticals: Evolving Trends in Market Access," a new study conducted by Avalere Health and commissioned by Janssen Biotech, Inc. and Johnson & Johnson Health Care Systems.